Tatva Chintan Pharma Chem Limited announced that at its Board Meeting held on May 5, 2023, the Board Recommended a Final Dividend of INR 2/- (20%) per equity share of INR 10/-each fully paid (subject to deduction of tax, if any) on the equity share capital of INR 22,16,50,620/- (2,21,65,062 equity shares of INR 10/- each) for the financial year 2022-23. This shall be paid subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.